Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2023-07-05 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - NARFURAPHINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS CO-DEVELOPED BY 3SBIO INC. AND TORAY IN JAPAN APPROVED FOR LAUNCH IN THE MARKET
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding the approval of a new drug application for narfuraphine hydrochloride orally disintegrating tablets by the National Medical Products Administration of China. It includes detailed information about the drug, clinical trials, and company background. The document is not a financial report, earnings release, or regulatory filing related to financial performance. It is a press release announcing a product approval, which is a corporate announcement rather than a financial or governance report. The document length is over 10,000 characters, indicating it is a full announcement rather than a brief notice. Given the content and nature, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories such as earnings, management changes, or capital updates.
2023-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return concerning movements in securities, specifically focusing on authorized and issued shares, share options, convertible bonds, and other share capital changes for 3SBio Inc. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with Exchange Listing Rules under Chapter 19B. The document includes detailed tables of share capital movements, share options, convertible bonds, and confirmations related to securities issued or redeemed during the month ended 30 June 2023. It is not a full annual or interim financial report, nor is it an earnings release or management discussion. It is a regulatory filing providing detailed share capital and securities movement information as required by the exchange. The document length (8196 characters) and content indicate it is a substantive regulatory compliance filing rather than a brief announcement or report publication notice. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-07-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 June 2023. It details movements in authorised/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance status for a specific month. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to share capital movements and compliance with listing rules. The document length is 4463 characters, which is relatively short and consistent with a regulatory filing rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-07-03 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for 3SBio Inc. It references specific listing rules from the Stock Exchange of Hong Kong (SEHK) and details share repurchases and bond redemptions convertible into shares. The content focuses on disclosures about share capital changes and repurchases, including dates, prices, and quantities. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about capital changes, fitting the category of Share Issue/Capital Change announcements rather than a full report or other categories. Therefore, the appropriate classification is SHA (Share Issue/Capital Change). The document length and detail support a high confidence in this classification.
2023-06-30 English
(1) ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS (2) REDEMPTION OF CONVERTIBLE BONDS PURSUANT TO EXERCISE OF PUT OPTION BY BONDHOLDERS
Capital/Financing Update Classification · 95% confidence The document is an announcement from 3SBio Inc. regarding adjustments to the conversion price of its convertible bonds and the redemption of convertible bonds following the exercise of put options by bondholders. It references previous announcements and annual results announcements but does not contain full financial statements or detailed financial analysis itself. The document is relatively short (4774 characters) and serves to inform about specific financing and bond-related updates rather than presenting a full report or detailed financial data. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2023-06-29 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2023' and contains detailed voting results for resolutions proposed at the AGM, including re-election of directors, dividend declaration, auditor appointment, and share mandates. It references the AGM notice and circular but does not contain full financial statements or detailed reports. The content is focused on the official announcement of shareholder voting outcomes at the AGM. The document length is 6239 characters, which is sufficient to include detailed poll results but not a full annual report or financial statements. Therefore, this document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-06-20 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.